Skip to main content
is now part of

User account menu

  • Log in
X

Main navigation

  • Specialties
    • Alzheimer Disease
    • Migraine
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuromuscular Disorders
    • Pain Medicine
    • Parkinson Disease
    • Seizures
    • Sleep Medicine
    • Spinal Disorders
    • Stroke & Vascular
    • Traumatic Brain Injury
  • Resources
    • News
    • Expert Insights
    • Interactive Features
    • Neurology Advances
    • Podcasts
    • Videos
  • Excellence Forums
    • Alzheimer Disease
    • Migraine
    • Multiple Sclerosis
    • Pain Medicine
    • Parkinson Disease
    • Seizures
    • Sleep Medicine
    • Stroke & Vascular
    • Traumatic Brain Injury
  • Meetings
    • AAN Annual Meeting
    • AAN Sports Concussion Conference
    • AHS Annual Scientific Meeting
    • APSS SLEEP 2020
    • Alzheimer's Association International Conference
    • CMSC Annual Meeting
    • ECTRIMS/ACTRIMS Joint Triennial Meeting
  • CME
    • Migraine 360
    • Program Listing
  • About
    • Contact Us
    • Editorial Description
Featured
Key Takeaways from the PROMISE-2 Trial of Eptinezumab for Migraine
In this video, Richard Lipton, MD, reviews key findings from the PROMISE-2 trial of eptinezumab for the treatment of chronic migraine.
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Psychotropic Treatment Classes and Options
Lori Kostich, CCC-SLP, on Managing Dysphagia in Multiple Sclerosis
Managing MS During the Pandemic: DMTs, Telemedicine, and More
Dawn Buse, PhD, on the OVERCOME Study
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: The Role of Psychotropics
Matthew Robbins, MD: The State of Headache Medicine During COVID-19
Urvish Patel, MD, on Status Migrainosus Triggers and Impact on Morbidity
Advantages of Intravenous Eptinezumab in the Treatment of Migraine

News

Stroke Alarm Clock Could Expedite Acute Stroke Management
MDS Virtual Congress 2020: Directional vs Omnidirectional DBS in Parkinson, and More
ECNP Virtual Congress Roundup: Data Mining Method Detects Psychosis Risk Early; Electroconvulsive Therapy Cuts Suicide Risk by 84% in Bipolar Disorder; and More
Early Intensive Treatment vs Escalation: Which is More Effective for RRMS?
Rituximab for MS: New Safety, Efficacy Data Presented at MSVirtual2020
ICH: Intensive SBP Reduction May Be Tied to Neurological Deterioration Among Patients With Excessively High Initial SBP
View More

Excellence Forums

Alzheimer Disease
Migraine
Multiple Sclerosis
Sleep Medicine
Stroke & Vascular

Newsrooms

AAN Sports Concussion Conference
AHS Annual Scientific Meeting
Alzheimer’s Association International Conference
APSS SLEEP 2020
ECTRIMS/ACTRIMS Joint Triennial Meeting

Education

Migraine 360
Optimizing Multiple Sclerosis Management through the Patient-Centered Medical Home
Migraine360: Translating a Novel Treatment Paradigm to Real-World Clinical Practice
Migraine Prevention: New Opportunities for Pain Relief
Migraine Prevention: New Opportunities for Pain Relief
Stay in the know.
NLN Newsletter

CONNECT

  • Facebook
  • Twitter
  • Linkedin

ABOUT

Footer

  • About Us
  • Contact Us
  • Privacy Policy

VISIT OUR OTHER BRANDS

Footer Brands

  • Migraine 360
  • Psychiatry & Behavioral Health Learning Network
© 2020 HMP. Rx Summit is a trademark of HMP. All Rights Reserved.